Company profile: CTT Pharmaceutical Holdings
1.1 - Company Overview
Company description
- Provider of intraoral, quick-dissolving drug delivery systems, including thin film Dissolvable Strips for local/systemic absorption on the tongue, Med Strips for pain management and inflammation, and VetWAFE for pain management in pets. Also offers pharma partnering services with proprietary drug delivery technology to help bring products to market faster.
Products and services
- Dissolvable Strips: Intraoral thin-film, thin and flexible, quickly dissolving on the tongue to release active agents for local or systemic absorption
- Pharma Partnering: Proprietary collaborative service that delivers drug delivery technology to pharmaceutical partners, helping bring products to market faster
- Med Strips: Saliva-activated oral thin strips for pain management and inflammation, dissolving in saliva within seconds without the need for water
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CTT Pharmaceutical Holdings
PharmaFluidics
HQ: Belgium
Website
- Description: Provider of integrated milli- to nano-engineered solutions for mixing, separation and reaction processes, offering high-quality, tailor-made designs. Products include μPAC Neo silicon-based HPLC columns for high-resolution separations; EASY-Spray and Double nanoViper columns for nano/capillary LC-MS and robust proteomics; MAbPac RP for intact protein characterization; Accucore 150 Amide HILIC for hydrophilic biomolecules/glycans.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaFluidics company profile →
Idaho Molecular
HQ: United States
Website
- Description: Provider of devices that help labs, hospitals, and research facilities make data driven decisions, using biotechnology to improve human lives.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Idaho Molecular company profile →
NuAire
HQ: United States
Website
- Description: Provider of ergonomic laboratory equipment for Life Science, Clinical, and Industrial research applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NuAire company profile →
Nanoplex Technologies
HQ: United States
Website
- Description: Provider of nanoparticle-based products for life science research, enabling ultra-sensitive molecular identification and quantitation, as well as authentication and tracking applications; focused on rapidly translating state-of-the-art nanoscience into practical, valuable products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanoplex Technologies company profile →
FloDesign Sonics
HQ: United States
Website
- Description: Provider of acoustic separation and filtration solutions leveraging 3D acoustic standing waves to capture, separate, and purify without physical membranes, chemicals, or centrifugation, with numerous applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FloDesign Sonics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CTT Pharmaceutical Holdings
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CTT Pharmaceutical Holdings
2.2 - Growth funds investing in similar companies to CTT Pharmaceutical Holdings
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CTT Pharmaceutical Holdings
4.2 - Public trading comparable groups for CTT Pharmaceutical Holdings
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →